(Date:5/15/2008)...a newly cleared device to identify the, lipid cor...sociated with complications of c...wswire/ -- InfraReDx, Inc. today,announced that ph... have,successfully used its LipiScan(TM) Coronary ...atheterization. This is the first patient in the,w...
(Date:5/15/2008)...RNewswire/ -- Tigris Pharmaceuticals,Inc. announc...nd,Development Agreement (CRADA) with the National... and preclinical development of AFP-464, an,aminof...s converted to,metabolites which bind covalently t... This is part of a four-year CRADA encompassing m...
(Date:5/15/2008)... CEA Trial data reports in third quarter ... /- VIA Pharmaceuticals,In...ed on the development of,compounds for the treatme...,it has completed patient enrollment in its acute ...e of three Phase 2 trials investigating VIA-2291,...
(Date:5/14/2008)...Newswire-FirstCall/ -- Progen,Pharmaceuticals Limi...he,Company has resumed patient enrolment in the ph...ed polyamine analogue, PG-11047 (formerly CGC-1104... commenced development of PG-11047 - the lead clin... following its acquisition of,Cellgate, Inc earlie...
Breaking Medicine Technology:First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 2Study by Pittsburgh researchers identifies possible vaccine target for chlamydia 358 1Study by Pittsburgh researchers identifies possible vaccine target for chlamydia 358 2A step toward tissue engineered heart structures for children 355 1A step toward tissue engineered heart structures for children 355 2Microbiotic technology developed for microinjection of zebrafish embryos 1069 1Mathematics might save you a trip to the ER 1066 1Mathematics might save you a trip to the ER 1066 2...-May 21, 2007 - Medical,professionals seeking to t...cquired gram-negative pneumonia may have a new wea...ct candidate being,developed by Nektar Therapeutic...rial evaluating the use of,NKTR-061 (Inhaled Amika...h hospital-acquired gram-negative pneumonia were,p...
...ed by FDA for long-term,maintenance treatment of C...bulized formoterol fumarate provides improved lung...anced patient quality of,life, and positive safety... presented at the,International Conference of the ...erforomist™ (formoterol fumarate),Inhalation...
Other Medicine Technology:Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7(Date:5/16/2008)...this country needs is more unemployed politicians ...ire-FirstCall/ -- Although nearly all,voters place...ssues" list,a looming federal budgetary crunch me...of the current presidential candidates is likely t... Majority Leader Bill Frist., Jousting with Princ...
(Date:5/16/2008)...RISBURG, Pa., May 16 /PRNewswire-USNewswire/ -- Em...opportunity to highlight the dedication,of Pennsyl...ns to become,trained EMS volunteers, according to ...is year,s theme, "EMS: Your Life is Our Mission," ... when it occurs, EMS is there to provide,immediate...
(Date:5/16/2008)...HINGTON, May 16 /PRNewswire-USNewswire/ -- As trop...f the Irrawaddy delta, survivors of,Cyclone Nargis...ems. Many,survivors still need assistance, as expo...ting an increasingly dire situation., "The people...p to,recover from this disaster and get back on th...
(Date:5/16/2008)...ppeals for Funds Focus on Millions of Children Sti...e U.S. Fund for UNICEF and The,Advertising Council...romote,a series of national public service announc...ing Ben Stiller, Nicole Ritchie, Joel Madden, Davi... to help survivors of the,Myanmar cyclone. The Ad ...
Breaking Medicine News(10 mins):Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:PA Secretary of Health Announces 'Emergency Medical Services Week,' May 18 - 24 2Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3Aaron manufactures two groups of flexible lighting products. The first is available both sterile and non-sterile in three different sizes 5", 10", and 15" (refers to the flexible shaft portion of the
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include
...des of Operation: , Standby: A standby switch main...timulus pulses. , Double Burst : 2 60-ms bursts of...itch: 1 s (1 pulse/s); 2 Hz (2 pulses/s) , Tetanu...Train-Of-Four: 4 pulses/2 s; repeats every 10 s , ...
Medicine Products: